mafosfamide has been researched along with ifosfamide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhardt, C; Coerper, C; Golbach, G; Klein, HO; Voigt, P | 1 |
| de Groot, CJ; Hagenbeek, A; Martens, AC | 1 |
| Brock, N | 1 |
| Brock, N; Hilgard, P; Peukert, M; Pohl, J; Sindermann, H | 1 |
| Hilgard, P | 1 |
| Botzler, C; Issels, R; Kis, K; Multhoff, G | 1 |
| Arends, J | 1 |
| Battaglia, S; Corradini, N; Delattre, O; Dumoucel, S; Gouin, F; Heymann, D; Lamoureux, F; Laud, K; Odri, GA; Picarda, G; Redini, F; Rousseau, J; Tirode, F | 1 |
2 review(s) available for mafosfamide and ifosfamide
| Article | Year |
|---|---|
Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.
Topics: Cyclophosphamide; Humans; Ifosfamide; Mesna; Organ Specificity | 1989 |
Basis and new developments in the field of oxazaphosphorines.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Humans; Ifosfamide; Immunosuppressive Agents; Phosphoramide Mustards; Prodrugs | 1988 |
1 trial(s) available for mafosfamide and ifosfamide
| Article | Year |
|---|---|
Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Humans; Ifosfamide; Interferon-beta; Interferon-gamma; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1991 |
5 other study(ies) available for mafosfamide and ifosfamide
| Article | Year |
|---|---|
Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
Topics: Animals; Antineoplastic Agents; Cell Line; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplastic Stem Cells; Rats; Rats, Inbred BN | 1991 |
Current status of oxazaphosphorine analogue development.
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry; Cyclophosphamide; Humans; Ifosfamide | 1987 |
A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
Topics: Antineoplastic Agents; Cell Division; Cells, Cultured; Cyclophosphamide; Glutathione; Humans; Ifosfamide; Immunosuppressive Agents; Lymphocyte Activation; T-Lymphocyte Subsets | 1997 |
Effects of a combined thermochemotherapy on markers of apoptosis, differentiation and adhesion in the human mammary carcinoma MX-1. A light microscopic and immunohistochemical study.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Breast Neoplasms; Cell Adhesion; Cell Differentiation; Cyclophosphamide; Desmosomes; Female; Humans; Hyperthermia, Induced; Ifosfamide; Immunohistochemistry; Keratins; Mice; Mice, Nude; Mucin-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Vimentin | 2000 |
Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cyclophosphamide; Diphosphonates; Drug Synergism; Humans; Ifosfamide; Imidazoles; Male; Mice; Mice, Nude; Sarcoma, Ewing; Zoledronic Acid | 2010 |